Page last updated: 2024-10-18

glycerol and Infections, Respiratory

glycerol has been researched along with Infections, Respiratory in 7 studies

Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.

Research Excerpts

ExcerptRelevanceReference
"Prior influenza vaccination had no effect on study outcome."2.84Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. ( Adkins, I; Arters, K; Buchheit, K; Esper, F; Ghannoum, MA; Mukherjee, PK; Salata, RA, 2017)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Davison, G1
Perkins, E1
Jones, AW1
Swart, GM1
Jenkins, AR1
Robinson, H1
Dargan, K1
Miler, JA1
Hajek, P1
Clarsund, M1
Blom, U1
Gardulf, A1
Mukherjee, PK1
Esper, F1
Buchheit, K1
Arters, K1
Adkins, I1
Ghannoum, MA1
Salata, RA1
Gliemroth, J1
Bahlmann, L1
Klaus, S1
Klöhn, A1
Arnold, H1
WAREMBOURG, H1
LEKIEFFRE, J1
CANCURA, W1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo to Prevent Acute Upper Respiratory Disease and Respiratory Virus Infections[NCT02644135]100 participants (Actual)Interventional2013-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Acute Respiratory Illnesses

Measured by medical record review. (NCT02644135)
Timeframe: Through study duration, an average of 3 months

InterventionNumber of acute respiratory illnesses (Number)
Halo Oral Spray4
Halo Placebo2

Number of Participants That Develop Acute Respiratory Illnesses When Using Halo vs Placebo

(NCT02644135)
Timeframe: Through study duration, an average of 3 months

Interventionparticipants (Number)
Halo Oral Spray2
Halo Placebo4

Trials

2 trials available for glycerol and Infections, Respiratory

ArticleYear
Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
    European journal of sport science, 2021, Volume: 21, Issue:5

    Topics: Adult; Antiviral Agents; Athletes; Athletic Performance; Bicycling; Common Cold; Drug Administration

2021
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
    BMC infectious diseases, 2017, 01-14, Volume: 17, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Infective Agents, Local; Cety

2017

Other Studies

5 other studies available for glycerol and Infections, Respiratory

ArticleYear
Resolution of chronic nasal Staphylococcus aureus infection in a non-smoker who started to use glycerine based e-cigarettes: Antibacterial effects of vaping?
    Medical hypotheses, 2018, Volume: 118

    Topics: Anti-Bacterial Agents; Electronic Nicotine Delivery Systems; Glycerol; Humans; Male; Middle Aged; Ne

2018
Evaluation of ColdZyme® Mouth Spray on prevention of upper respiratory tract infections in a boy with primary immunodeficiency: a case report.
    Journal of medical case reports, 2016, Oct-31, Volume: 10, Issue:1

    Topics: Administration, Oral; Child; Common Variable Immunodeficiency; Glycerol; Humans; Immunoglobulin G; M

2016
Long-time microdialysis in a patient with meningoencephalitis.
    Clinical neurology and neurosurgery, 2002, Volume: 105, Issue:1

    Topics: Adult; Brain Edema; Combined Modality Therapy; Diuretics, Osmotic; Glucose; Glutamic Acid; Glycerol;

2002
[Experimentation with a combination of tetracycline, glycerol and phenoxyl].
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1963, Volume: 8

    Topics: Bronchial Diseases; Glycerol; Humans; Lung Diseases; Protein Synthesis Inhibitors; Respiratory Tract

1963
[On the treatment of inflammatory diseases of the upper respiratory tract with aerosols].
    Wiener medizinische Wochenschrift (1946), 1963, Apr-06, Volume: 113

    Topics: Aerosols; Anti-Infective Agents, Local; Glycerol; Humans; Mercury Compounds; Respiratory System; Res

1963